its 18%

From Q&A,

"Operator

The next question is from Prakash Agarwal from RBS.

Prakash Agarwal - RBS Research

A follow-up on Fondaparinux, actually. Just trying in understanding, this 18% market share is taking in account of retail as well as hospitals, or only the retail 40% market?

Kallam Satish Reddy

Prakash, we have -- this 18% market is for the entire molecule. And currently, we are holding the retail part of the segment.

Prakash Agarwal - RBS Research

Okay. So we have fairly good market share in the retail segment currently.

Gunupati Venkateswara Prasad

Yes.

Umang Vohra

That's right.

Prakash Agarwal - RBS Research

And in next 3 months, you expect to come into hospital segment as well?

Kallam Satish Reddy

Next 3 months, we expect to address our manufacturing issues totally, after which the supply [indiscernible] is ramped up."